Jiang et al. [40] demonstrated that miR-491 involved in arsenic trioxide-induced antiangiogenesis in HCC via inhibiting the TGF-β/smad3/NF-κB signaling pathway. The gene discussed is SMAD3; the disease is hepatocellular carcinoma.